| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Quality Provider Services is a Richmond, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lifespark is a complete senior health company that helps people stay healthy at home, navigate their health options with confidence, and live fuller, more independent lives.
Senior Whole Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Senior Whole Health is based in Cambridge, MA. You can find more information on Senior Whole Health at www.seniorwholehealth.com
Pharmaceutical Research - Oregon is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.